| Literature DB >> 33828807 |
Wolfgang H Zangemeister, Christof Heesen1, Dorit Röhr1, Stefan M Gold1.
Abstract
Fatigue is a major complaint in MS. Up to now no objective assessment tools have been established which hampers any treatment approach. Previous work has indicated an association of fatigue with cognitive measures of attention. Oculomotor tests have been established in healthy individuals as a read-out of fatigue, and to some extent in MS patients. Based on these observations we compared two groups of MS patients, one with fatigue (n=28) and one without fatigue (n=21) and a group of healthy subjects (n=15) with a standardised computerised measure of alertness and an oculomotor stress test. Patients with fatigue showed highly significant changes of their saccade dynamics as defined by the Main Sequence and Phase Plane plots: They showed slowing of saccades, the characteristical fatigue double peak, and an asymmetrical phase plane. Oculomotor tests differentiated significantly between fatigue and fatigabiliy in our MS patients. They also showed significantly worse performance in the alertness test as well as in the oculomotor task. Significantly slower reaction times were observed for tonic alertness in 2 series without a cue (p=.025 and p=.037) but not in phasic alertness with a cue (p=.24 and p=.34). Performance was influenced by disability as well as by affective state. We conclude, when controlling for disability and depression, saccadic stress tests and alertness tests could be used as an objective read-out for fatigability and fatigue in MS patients.Entities:
Keywords: Eye Movements; Fatigue; Multiple Sklerosis; Neuropsychological assessment; Saccade velocity
Year: 2020 PMID: 33828807 PMCID: PMC8006090 DOI: 10.16910/jemr.13.4.6
Source DB: PubMed Journal: J Eye Mov Res ISSN: 1995-8692 Impact factor: 0.957
Demographic and clinical characteristics of patient sample.
| MS Fatigue (n=28) | MS non-Fatigue (n=21) | P* | |
| Age | 41.7 +-1.4 | 40.05+-2.16 | n.s. |
| Gender (F/M) | 26 / 2 | 15 / 6 | 0.06 |
| Disease duration | 6.00+-1.0 | 5.62+-1.1 | n.s. |
| EDSS | 3.0+-0.1 | 2.3+-0.3 | 0.06 |
| SDMT | 56.4+-1.6 | 60.1+-3.1 | n.s. |
| 9-HPT | 18.2+-0.5 | 18.2+-0.7 | n.s. |
Note. *according to independent samples t-tests
Self-report measures of fatigue and depression.
| MS Fatigue (n=28) | MS non-Fatigue (n=21) | P* | |
| FSS | 5.60+-0.15 | 1.73 +-0.24 | p< .001 |
| MFIS phys | 23.25+-1.18 | 6.00+-1.28 | p< .001 |
| MFIS cog | 25.68+-1.30 | 6.95+-1.68 | p< .001 |
| MFIS psych | 4.39+-0.35 | 0.86+-0.27 | p< .001 |
| BDI | 14.17+-1.25 | 4.86+-0.96 | p< .001 |
Note. *according to independent samples t-tests
Statistical results (student´s t-test in confirmed Gaussian distribution of IR-OG values) of infrared oculography in MS patients with and without fatigue before (pre-) and after (post-) the oculomotor stress test.
| pV/Ampl | N | Pre stress test P* | Post stress test P* |
| NOR | 15 | 0.42 | |
| NOR/ MS-Non-Fatigue | 0.29 | ||
| MS Non-Fatigue | 21 | 0.1 | |
| MS Non-Fatigue/ MS Fatigue | 0.83 | ||
| MS Fatigue | 28 | ||
| NOR/ MS Fatigue | 0.24 |
TAP alertness in MS patients with and without fatigue
| MS Fatigue (n=28) | MS non-Fatigue (n=21) | P* | |
| Series 1 | 397.3+-44.9 | 260.7+-13.9 | .025 |
| Series 2 | 352.3-37.2 | 268.6+-11.5 | .24 |
| Series 3 | 348.0+-38.3 | 261.6+-10.8 | .31 |
| Series 4 | 412.6+-53.4 | 282.6+-17.8 | .037 |
Note. *according to Man Whitney U test
Correlations ( Spearman Rho) TAP and SDMT, EDSS, BDIaff, 9-HPT.
| Parameter | TAP Series 1 | TAP Series 2 | TAP Series 3 | TAP Series 4 |
| FSS | 0.389** | 0.220* | 0. 177 | 0.351* |
| EDSS | 0.33* | 0.29* | 0.29* | 0.36* |
| BDI affect | 0. 185 | 0. 55 | 0. 092 | 0. 127 |
| 9-HPT | 0.375* | 0.418** | 0.466** | 0.380* |
Note. *significance <0.05, ** significance <0.01
Correlations (Spearman Rho) between IR-OG results after stress test with MFIS Cog, 9-HPT.
| MFIS | 9-HPT | |||
| Saccade | MfisScore Rho | P value | 9-HptScore Rho | P value |
| Peak + Acceleration | 0.307 | 0.004 | -0.307 | 0.01 |
| Peak Velocity | 0. 300 | 0. 01 | -0.321 | 0. 02 |
| Amplitude | 0.265 | 0.09 | 0.377 | 0.05 |
| Duration | -0.311 | 0.05 | 0.103 | 0.110 |
Correlations ( Spearman Rho) TAP and SDMT and EDSS
| Parameter | TAP Series 1 | TAP Series 2 | TAP Series 3 | TAP Series 4 |
| FSS | 0.389** | 0.220* | 0. 177 | 0.351* |
| MFIS Cog | 0.342* | 0. 197 | 0. 155 | 0. 276 |
| MFIS Physe | 0.385** | 0. 224 | 0. 201 | 0.345* |
| MFIS PsySoz | 0.502** | 0.296* | 0. 279 | 0.419** |
| HA Cog | 0.346* | 0. 205 | 0. 140 | 0.337* |
| HA Fat | 0.304* | 0. 162 | 0. 118 | 0.290* |
| BDI Affect | 0. 185 | 0. 55 | 0. 092 | 0. 127 |
| BDI | 0.406** | 0. 211 | 0. 188 | 0.343* |
| SDMT | 0.381* | 0.357* | 0. 230 | 0.431* |
| EDSS | 0.326* | 0.293* | 0.289* | 0.357* |
| 9-HPT | 0.375* | 0.418** | 0.466** | 0.380* |
Note. *significance <0.05, ** significance <0.01